D.E. Shaw & Co’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

D.E. Shaw & Co’s Portfolio EBACW Stock Details EBACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-37,216	Closed	-$9.3K	–	5149
2022 Q4	$9.3K	Hold	37,216	–	–	﹤0.01%	4618
2022 Q3	$4K	Hold	37,216	–	–	﹤0.01%	5056
2022 Q2	$6K	Hold	37,216	–	–	﹤0.01%	5216
2022 Q1	$7K	Hold	37,216	–	–	﹤0.01%	5446
2021 Q4	$22K	Hold	37,216	–	–	﹤0.01%	5291
2021 Q3	$21K	Buy	37,216 +26,105	+235%	+$20.3K	﹤0.01%	4892
2021 Q2	$11K	Buy	+11,111	New	+$10.3K	﹤0.01%	4717

D.E. Shaw & Co's EBACW Position: Q1 2023 in Review

D.E. Shaw & Co sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 37,216 shares — an estimated $9.3K sold.

D.E. Shaw & Co first reported a position in EBACW in Q2 2021 and held it in 7 quarters. The position peaked at $22K in Q4 2021. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

D.E. Shaw & Co reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
D.E. Shaw & Co sold 37,216 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $9.3K.
D.E. Shaw & Co first reported a position in European Biotech Acquisition Corp. Warrant in Q2 2021 and held it in 7 quarters.
D.E. Shaw & Co's European Biotech Acquisition Corp. Warrant position peaked at $22K in Q4 2021.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.